AustinPx Gains FDA AMT Designation for KinetiSol Technology
GEORGETOWN, Texas — September 15, 2026 AustinPx announced that the U.S. Food and Drug Administration’s Center for Drug Evaluation...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
GEORGETOWN, Texas — September 15, 2026 AustinPx announced that the U.S. Food and Drug Administration’s Center for Drug Evaluation...
Yantai, China — September 7, 2026 CelluPro, Ltd. announced that it has received EXCiPACT™ GMP Certification for Pharmaceutical Auxiliary...
Montreal, Canada, and Charlotte, North Carolina, USA, August 21, 2026 Milestone Pharmaceuticals has announced the initiation of its pivotal...
Toronto, Ontario, Canada, August 21, 2026 PharmAla Biotech Holdings Inc., a biotechnology company focused on the research, development, and...
Scottsdale, Arizona, August 19, 2026 Allure Beauty Concepts has converted its Scottsdale facility into a fully FDA-registered, cGMP-compliant over-the-counter...
New Delhi, India & New York, United States, August 19, 2026 Zeon Lifesciences, an India-based nutraceutical manufacturer, has strengthened...
Charleston, South Carolina, August 12, 2026 Salus Scientific announced the launch of its Clinical Insights Series, a new publication...
Shanghai, China, August 12, 2026 Aurisco Pharmaceutical announced that its manufacturing site in Yangzhou, China, has successfully passed a...
MILPITAS, Calif. & FREDERICK, Md., July 8, 2026 RoosterBio and Applied StemCell (ASC) have announced a strategic partnership to...
RANCHO CORDOVA, Calif., June 23, 2026 SK pharmteco has introduced SKyvec™, a next-generation multimodal viral vector platform designed to...
